Projects per year
Fingerprint Dive into the research topics where Christopher Ryan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 17 Similar Profiles
docetaxel
Medicine & Life Sciences
Prostatic Neoplasms
Medicine & Life Sciences
Androgens
Medicine & Life Sciences
Renal Cell Carcinoma
Medicine & Life Sciences
Sarcoma
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Prostate-Specific Antigen
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2011 2016
- 1 Finished
Shutter-Speed Model DCE-MRI for Assessment of Response to Cancer Therapy
9/1/11 → 8/31/16
Project: Research project
Biomarkers
Neoplasms
Therapeutics
Blood Vessels
Water
Research Output 1998 2019
1
Citation
(Scopus)
Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma
Patel, S., von Mehren, M., Reed, D. R., Kaiser, P., Charlson, J., Ryan, C., Rushing, D., Livingston, M., Singh, A., Seth, R., Forscher, C., D'Amato, G., Chawla, S. P., McCarthy, S., Wang, G., Parekh, T., Knoblauch, R., Hensley, M. L., Maki, R. G. & Demetri, G. D., Aug 1 2019, In : Cancer. 125, 15, p. 2610-2620 11 p.Research output: Contribution to journal › Article
Open Access
trabectedin
Liposarcoma
Dacarbazine
Leiomyosarcoma
Histology
5
Citations
(Scopus)
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
Tap, W. D., Gelderblom, H., Palmerini, E., Desai, J., Bauer, S., Blay, J. Y., Alcindor, T., Ganjoo, K., Martín-Broto, J., Ryan, C., Thomas, D. M., Peterfy, C., Healey, J. H., van de Sande, M., Gelhorn, H. L., Shuster, D. E., Wang, Q., Yver, A., Hsu, H. H., Lin, P. S. & 3 others, , Aug 10 2019, In : The Lancet. 394, 10197, p. 478-487 10 p.Research output: Contribution to journal › Article
Placebos
Macrophage Colony-Stimulating Factor
Giant Cell Tumor of Tendon Sheath
Clinical Trials Data Monitoring Committees
Colony-Stimulating Factor Receptors
7
Citations
(Scopus)
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
Davis, L., Bolejack, V., Ryan, C., Ganjoo, K. N., Loggers, E. T., Chawla, S., Agulnik, M., Livingston, M. B., Reed, D., Keedy, V., Rushing, D., Okuno, S., Reinke, D. K., Riedel, R. F., Attia, S., Mascarenhas, L. & Maki, R. G., Jun 1 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 16, p. 1424-1431 8 p.Research output: Contribution to journal › Article
Osteosarcoma
Disease-Free Survival
Placebos
Sarcoma
Clinical Trials Data Monitoring Committees
18
Citations
(Scopus)
Adjuvant Vascular Endothelial Growth Factor–targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis
Sun, M., Marconi, L., Eisen, T., Escudier, B., Giles, R. H., Haas, N. B., Harshman, L. C., Quinn, D. I., Larkin, J., Pal, S. K., Powles, T., Ryan, C., Sternberg, C. N., Uzzo, R., Choueiri, T. K. & Bex, A., Jan 1 2018, (Accepted/In press) In : European Urology.Research output: Contribution to journal › Article
Renal Cell Carcinoma
Blood Vessels
Growth
Vascular Endothelial Growth Factor Receptor
Disease-Free Survival
ASO Author Reflections: Chemoradiation for High-Risk Soft Tissue Sarcomas
Lu, E. & Ryan, C., Jan 1 2018, (Accepted/In press) In : Annals of Surgical Oncology.Research output: Contribution to journal › Article
Sarcoma